Dynamic prediction modeling for cancer-associated venous thromboembolism.
作者信息
van Es Nick
机构信息
Department of Vascular Medicine, Amsterdam University Medical Center, Amsterdam, the Netherlands.
出版信息
J Thromb Haemost. 2020 Jun;18(6):1276-1277. doi: 10.1111/jth.14803.
Abstract
摘要
相似文献
1
Dynamic prediction modeling for cancer-associated venous thromboembolism.癌症相关静脉血栓栓塞的动态预测建模
J Thromb Haemost. 2020 Jun;18(6):1276-1277. doi: 10.1111/jth.14803.
2
Increased D-dimer predicts the risk of cancer-associated recurrent venous thromboembolism and venous thromboembolism: A systematic review and meta-analysis.D-二聚体升高可预测癌症相关复发性静脉血栓栓塞症和静脉血栓栓塞症的风险：一项系统评价和荟萃分析。
Thromb Res. 2020 Dec;196:410-413. doi: 10.1016/j.thromres.2020.09.031. Epub 2020 Sep 28.
3
Dynamic assessment of venous thromboembolism risk in patients with cancer by longitudinal D-Dimer analysis: A prospective study.通过纵向D-二聚体分析对癌症患者静脉血栓栓塞风险进行动态评估：一项前瞻性研究。
J Thromb Haemost. 2020 Jun;18(6):1348-1356. doi: 10.1111/jth.14774. Epub 2020 Apr 15.
4
D-dimer measured at first venous thromboembolism is associated with future risk of cancer.首次静脉血栓栓塞时检测的D-二聚体与未来患癌风险相关。
Haematologica. 2016 Dec;101(12):e473-e475. doi: 10.3324/haematol.2016.151712. Epub 2016 Sep 9.
5
Elevated fibrin-related markers in patients with malignant diseases frequently associated with disseminated intravascular coagulation and venous thromboembolism.恶性疾病患者体内纤维蛋白相关标志物升高，这些疾病常与弥散性血管内凝血和静脉血栓栓塞相关。
Intern Med. 2014;53(5):413-9. doi: 10.2169/internalmedicine.53.1102.
6
Postoperative D-dimer predicts venous thromboembolism in patients undergoing urologic tumor surgery.术后D-二聚体可预测接受泌尿外科肿瘤手术患者的静脉血栓栓塞。
Urol Oncol. 2018 Jun;36(6):307.e15-307.e21. doi: 10.1016/j.urolonc.2018.03.003. Epub 2018 Mar 26.
7
Maternal and pregnancy characteristics affect plasma fibrin monomer complexes and D-dimer reference ranges for venous thromboembolism in pregnancy.孕产妇及妊娠特征影响孕期静脉血栓栓塞症的血浆纤维蛋白单体复合物及D-二聚体参考范围。
Am J Obstet Gynecol. 2016 Oct;215(4):466.e1-8. doi: 10.1016/j.ajog.2016.05.013. Epub 2016 May 11.
8
Prediction of recurrent venous thromboembolism by endogenous thrombin potential and D-dimer.通过内源性凝血酶潜力和D - 二聚体预测复发性静脉血栓栓塞症
Clin Chem. 2008 Dec;54(12):2042-8. doi: 10.1373/clinchem.2008.112243. Epub 2008 Oct 23.
9
Effect of rosuvastatin on risk markers for venous thromboembolism in cancer.瑞舒伐他汀对癌症患者静脉血栓栓塞风险标志物的影响。
J Thromb Haemost. 2018 Jun;16(6):1099-1106. doi: 10.1111/jth.14004. Epub 2018 Apr 29.
10
Predictors and Causes of Long-Term Mortality in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study.老年急性静脉血栓栓塞症患者长期死亡率的预测因素及病因：一项前瞻性队列研究
Am J Med. 2017 Feb;130(2):198-206. doi: 10.1016/j.amjmed.2016.09.008. Epub 2016 Oct 11.
引用本文的文献
1
Individualized dynamic risk assessment and treatment selection for multiple myeloma.多发性骨髓瘤的个体化动态风险评估与治疗选择
Br J Cancer. 2025 Jun;132(10):922-936. doi: 10.1038/s41416-025-02987-6. Epub 2025 Apr 1.
2
External Validation of Risk Scores for Predicting Venous Thromboembolism in Ambulatory Patients with Lung Cancer.预测门诊肺癌患者静脉血栓栓塞风险评分的外部验证
Cancers (Basel). 2024 Sep 15;16(18):3165. doi: 10.3390/cancers16183165.
本文引用的文献
1
Dynamic assessment of venous thromboembolism risk in patients with cancer by longitudinal D-Dimer analysis: A prospective study.通过纵向D-二聚体分析对癌症患者静脉血栓栓塞风险进行动态评估：一项前瞻性研究。
J Thromb Haemost. 2020 Jun;18(6):1348-1356. doi: 10.1111/jth.14774. Epub 2020 Apr 15.
2
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.2019 年国际癌症患者静脉血栓栓塞症治疗和预防临床实践指南。
Lancet Oncol. 2019 Oct;20(10):e566-e581. doi: 10.1016/S1470-2045(19)30336-5. Epub 2019 Sep 3.
3
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update.静脉血栓栓塞症预防和治疗癌症患者：ASCO 临床实践指南更新。
J Clin Oncol. 2020 Feb 10;38(5):496-520. doi: 10.1200/JCO.19.01461. Epub 2019 Aug 5.
4
Dynamic models to predict health outcomes: current status and methodological challenges.预测健康结果的动态模型：现状与方法学挑战
Diagn Progn Res. 2018 Dec 18;2:23. doi: 10.1186/s41512-018-0045-2. eCollection 2018.
5
Long-term performance of risk scores for venous thromboembolism in ambulatory cancer patients.门诊癌症患者静脉血栓栓塞风险评分的长期表现。
J Thromb Thrombolysis. 2019 Jul;48(1):125-133. doi: 10.1007/s11239-019-01845-6.
6
A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts.一种癌症相关静脉血栓栓塞的临床预测模型：在两个独立前瞻性队列中的开发与验证研究
Lancet Haematol. 2018 Jul;5(7):e289-e298. doi: 10.1016/S2352-3026(18)30063-2. Epub 2018 Jun 7.
7
Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients.瓜氨酸化组蛋白 H3，中性粒细胞胞外诱捕网形成的生物标志物，可预测癌症患者发生静脉血栓栓塞的风险。
J Thromb Haemost. 2018 Mar;16(3):508-518. doi: 10.1111/jth.13951. Epub 2018 Feb 7.
8
A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study.与乳腺癌、结直肠癌、肺癌或卵巢癌相关的血栓形成的预测评分：前瞻性 COMPASS-癌症相关血栓形成研究。
Oncologist. 2017 Oct;22(10):1222-1231. doi: 10.1634/theoncologist.2016-0414. Epub 2017 May 26.
9
Hypercoagulabilty, venous thromboembolism, and death in patients with cancer. A Multi-State Model.癌症患者的高凝状态、静脉血栓栓塞与死亡。一种多状态模型。
Thromb Haemost. 2016 Apr;115(4):817-26. doi: 10.1160/TH15-09-0758. Epub 2016 Jan 7.
10
Epidemiology of cancer-associated venous thrombosis.癌症相关静脉血栓形成的流行病学。
Blood. 2013 Sep 5;122(10):1712-23. doi: 10.1182/blood-2013-04-460121. Epub 2013 Aug 1.
Zotero 插件